The shared expertise within AID enables:
- Drug discovery and optimisation, as well as repurposing of already existing therapeutics
- Drug administration and delivery
- Biologic discovery and development
- Clinical trials
- Multi- and cross-diciplinary collaborations for patient-focused outcomes
Impact:
- Discovery of antimicrobials from unique natural products and synthetic scaffolds
- Lead characterisation, optimisation, and pre-/early clinical validation
- Novel drug combinations
- Host-directed interventions in chronic infections (e.g., compassionate use)
- Clinical trials on optimal antibiotic delivery for accelerated pathogen clearance (e.g., RESPOND)
- Clinical trials on drug combinations and new delivery modes in chronic infection (e.g., FORMAT)
A pledge to AID goes directly into the research of issues that impact the lives of many people and their families.